December 24, 2018 7:27am
Peace and goodwill in markets, a rebound of the oversold, and at the minimum - pennies for my portfolio!
Pre-open indication: 3 TRADEs
The NYSE closes early on Monday at 1 p.m. The exchange is closed on Tuesday for Christmas day. Wednesday through Friday are normal trading days.
I answer one question, in which company should investors put, keep and commit their money!
Which pre-market indication is actually performance based?
U.S. stock index futures point to a small Santa Claus gain
Dow futures are UP +0.41% (+92 points) and NASDAQ futures are UP +0.76% (+46 points)
U.S. stock futures pointed to a slightly higher open on Monday as the market attempted to rebound from a brutal week
European stocks lower in shortened session as thin volumes dampen trading activity
Asian equities were mixed after last week's market turmoil stateside.
Monday’s indications:
The iShares Nasdaq Biotechnology (IBB) is NOT indicating
The SPDR S&P Biotech ETF (XBI) is NOT indicating
The Health Care Select Sector SPDR ETF (XLV) is NOT indicating
The iShares Russell 2000 (IWM) is indicating a POSITIVE +0.4% UPSIDE
Henry’omics:
Let's all say thenk you; if could have been worse and forget ... for a few days !!
From Friday night’s post, “sector liquidates taking another huge loss with unprecedented volatility. Deleveraging, de-risking and the quadruple witching helped sweep the session clean as 45 covered companies, only 3 closed positive SLDB (+$0.13), OSIR (+$0.08) and BCLI (+$0.57).”
I also stated, “Sector equities collapsed for a seventh (7th) session with the NASDAQ and the S&P 500 down nearly -18% from its record earlier this year.”
Friday night’s percentage (%) indicators: weakness …
- Review the range of the 3 upside from +0.57% (SLDB) to +19.13% (BCLI) while the 42 downside ranged from -0.72% (HSGX) to -20.78% (EDIT) with 0 flat close
Volume stat: Increasing …
- 3 out of the 3 upside had higher (than the 3 month average) volume
- 35 out of the 42 downside experienced greater volume (than the 3 month average).
Quarterly history lesson:
- In 15 sessions in December – there were 4 positive close; 1 market close and 10 negative close;
- In 22 sessions in November – there were 1 holiday, 10 positive closes, 1 neutral and 10 negative closes;
- In 23 sessions in October – there were 17 negative closes and 6 positive sessions;
Companies in my headlights – It’s your decision; I provide an idea and context:
CRISPER Therapeutics (CRSP) closed down again -$4.69 to $22.73 after Thursday’s -$1.44 to $27.42, Wednesday’s -$0.58 to $28.86, Tuesday’s -$2.04 to $29.54 and last Monday’s -$1.11 to $31.58. What a year: January 2, 2017 CRSP was the lowest of the year at $25.17, having closed 12/20/17 at $23.48– TRADE;
Editas medicine (EDIT) closed down again -$4.77 to $18.19 after Thursday’s-$1.99 to $22.96, Wednesday’s -$1.36 to $24.95, Tuesday’s -$1.33 to $26.31 and last Monday’s -$0.81 to $27.64. What a year: January 2, 2017 EDIT was priced at $34.32, having closed 12/29/17 at $30.73 - TRADE;
Intellia (NTLA) closed up down -$2.33 to $11.39 after Thursday’s +$0.27 to $13.72, Wednesday’s -$1.13 to $13.45, Tuesday’s -$0.69 to $14.58 and last Monday’s -$0.46 to $15.27. What a year: January 2, 2017 NTLA was priced at $21.51, having closed 12/29/17 at $19.22 – TRADE;
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
